The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).
 
Martin J. Van Den Bent
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Celldex; Daiichi Sankyo; MSD
Research Funding - Abbvie (Inst)
 
Pim French
Employment - BMS Brazil (I)
Stock and Other Ownership Interests - BMS Brazil (I)
Research Funding - Abbvie
 
Marica Eoli
No Relationships to Disclose
 
Juan M. Sepúlveda
Consulting or Advisory Role - Bayer; Janssen; Pfizer
Speakers' Bureau - Astellas Medivation
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Anna Maria Elisabeth Walenkamp
Research Funding - Ipsen (Inst); Novartis (Inst)
 
Jean-Sebastien Frenel
Consulting or Advisory Role - AstraZeneca; Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Enrico Franceschi
No Relationships to Disclose
 
Paul M. Clement
Consulting or Advisory Role - Abbvie; BMS Brazil; LEO Pharma; Vifor Pharma
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck Serono
Patents, Royalties, Other Intellectual Property - NIH/NCI
 
Michael Weller
Honoraria - Lilly; Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celldex; Lilly; Merck Serono; Pfizer; Roche; Teva
Research Funding - Acceleron Pharma (Inst); Actelion (Inst); Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)
 
Iris de Heer
No Relationships to Disclose
 
Jim Looman
Employment - Abbvie
Leadership - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jyotirmoy Dey
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie; Novartis
 
Scott Krause
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Hao Xiong
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Peter J Ansell
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sarah Nuyens
No Relationships to Disclose
 
Maarten Spruyt
No Relationships to Disclose
 
Joana Brilhante
Consulting or Advisory Role - ANMI
Travel, Accommodations, Expenses - ANMI; GE Healthcare
 
Thierry Gorlia
No Relationships to Disclose
 
Vassilis Golfinopoulos
No Relationships to Disclose